The preliminary research, out of the Com-COV study of vaccine second doses led by University of Oxford researchers, involved 830 vaccine recipients from eight sites.
It reduced infection with the SARS-CoV-2 coronavirus by 57% and intensive care admissions by 95% in people who had received two vaccine doses.
I believe that if I should somehow get COVID, I'm likely to survive — and to enjoy a future full of those good things we're all asked to put on hold just a little while longer.